Clinical Trial Update: Study of the Prognostic Impact of CD44 on Renal Cell Carcinoma

View source ↗

Summary

This clinical trial investigates the prognostic impact of CD44 in renal cell carcinoma and is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Assiut University | Conditions: Renal Cell Cancer | Status: NOT_YET_RECRUITING